Maternal-Fetal Metabolic Research Group, Girona Institute for Biomedical Research, Salt, Spain.
Pediatric Endocrinology Research Group, Girona Institute for Biomedical Research, Salt, Spain.
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5285-5298. doi: 10.1210/jc.2018-02346.
Catch-up growth in infants who are small for gestational age (SGA) is a risk factor for the development of cardiometabolic diseases in adulthood. The basis and mechanisms underpinning catch-up growth in newborns who are SGA are unknown.
To identify umbilical cord miRNAs associated with catch-up growth in infants who are SGA and study their relationship with offspring's cardiometabolic parameters.
miRNA PCR panels were used to study the miRNA profile in umbilical cord tissue of five infants who were SGA with catch-up (SGA-CU), five without catch-up (SGA-nonCU), and five control infants [appropriate for gestational age (AGA)]. The miRNAs with the smallest nominal P values were validated in 64 infants (22 AGA, 18 SGA-nonCU, and 24 SGA-CU) and correlated with anthropometric parameters at 1 (n = 64) and 6 years of age (n = 30).
miR-501-3p, miR-576-5p, miR-770-5p, and miR-876-3p had nominally significant associations with increased weight, height, weight catch-up, and height catch-up at 1 year, and miR-374b-3p, miR-548c-5p, and miR-576-5p had nominally significant associations with increased weight, height, waist, hip, and renal fat at 6 years. Multivariate analysis suggested miR-576-5p as a predictor of weight catch-up and height catch-up at 1 year, as well as weight, waist, and renal fat at 6 years. In silico studies suggested that miR-576-5p participates in the regulation of inflammatory, growth, and proliferation signaling pathways.
Umbilical cord miRNAs could be novel biomarkers for the early identification of catch-up growth in infants who are SGA. miR-576-5p may contribute to the regulation of postnatal growth and influence the risk for cardiometabolic diseases associated with a mismatch between prenatal and postnatal weight gain.
小于胎龄儿(SGA)的婴儿追赶性生长是成年后患心血管代谢疾病的危险因素。SGA 新生儿追赶性生长的基础和机制尚不清楚。
鉴定与 SGA 婴儿追赶性生长相关的脐血 miRNA,并研究其与后代心血管代谢参数的关系。
使用 miRNA PCR 面板研究了 5 名 SGA 追赶性生长(SGA-CU)婴儿、5 名无追赶性生长(SGA-nonCU)婴儿和 5 名对照婴儿(适于胎龄(AGA))的脐血组织中的 miRNA 谱。对具有最小名义 P 值的 miRNA 在 64 名婴儿(22 名 AGA、18 名 SGA-nonCU 和 24 名 SGA-CU)中进行了验证,并与 1 岁(n=64)和 6 岁(n=30)时的人体测量参数相关。
miR-501-3p、miR-576-5p、miR-770-5p 和 miR-876-3p 与 1 岁时体重、身高、体重追赶生长和身高追赶生长增加具有名义显著相关性,miR-374b-3p、miR-548c-5p 和 miR-576-5p 与 6 岁时体重、身高、腰围、臀围和肾脏脂肪增加具有名义显著相关性。多变量分析表明,miR-576-5p 可预测 1 岁时体重追赶生长和身高追赶生长,以及 6 岁时体重、腰围和肾脏脂肪。计算机模拟研究表明,miR-576-5p 参与了炎症、生长和增殖信号通路的调节。
脐血 miRNA 可能是鉴定 SGA 婴儿追赶性生长的新生物标志物。miR-576-5p 可能有助于调节出生后生长,并影响与出生前和出生后体重增加不匹配相关的心血管代谢疾病风险。